MYG
(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside
Find entries where: MYG
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | (1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside |
Synonyms | GLUCOSAMINYL-(ALPHA-6)-D-MYO-INOSITOL; (1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucoside; (1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-2-deoxy-D-glucoside; (1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-2-deoxy-glucoside |
Identifiers | (1R,2R,4R,5S)-6-[(2R,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexane-1,2,3,4,5-pentol |
Formula | C12 H23 N O10 |
Molecular Weight | 341.312 |
Type | D-SACCHARIDE |
Isomeric SMILES | C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC2[C@@H]([C@@H](C([C@H]([C@@H]2O)O)O)O)O)N)O)O)O |
InChI | InChI=1S/C12H23NO10/c13-3-5(16)4(15)2(1-14)22-12(3)23-11-9(20)7(18)6(17)8(19)10(11)21/h2-12,14-21H,1,13H2/t2-,3-,4-,5-,6-,7-,8-,9+,10-,11-,12-/m1/s1 |
InChIKey | HEPUIGACZYVUCD-YZRQSVRMSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 46 |
Chiral Atom Count | 9 |
Bond Count | 47 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB03779 |
---|---|
Name | Glucosaminyl-(Alpha-6)-D-Myo-Inositol |
Groups | experimental |
Synonyms | Glucosaminyl-(Alpha-6)-D-Myo-Inositol |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
1-phosphatidylinositol phosphodiesterase | MSNKKLILKLFICSTIFITFVFALHDKRVVAASSVNELENWSKWMQPIPD... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682